Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 560 across all filing types
Latest filing 2024-03-07 Declaration of Voting R…
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
LUMIBIRD : nombre d'actions au 29 février 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (860 characters) and presents a table detailing the 'Nombre total de droits de vote et d'actions' (Total number of voting rights and shares) as of February 29, 2024. This information is explicitly required by French regulations (Articles L.233-8 II of the Commercial Code and 223-16 of the AMF General Regulation). This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory filing, often related to capital structure updates or required periodic disclosures, but it does not fit perfectly into the main categories like 10-K, ER, or IR. Given the options, it is a specific regulatory announcement concerning share capital/voting rights. While 'SHA' (Share Issue/Capital Change) is related, this is a periodic disclosure of the *total* count, not an announcement of a change event. 'RNS' (Regulatory Filings) is the most appropriate fallback for specific, mandatory regulatory disclosures that don't match the primary definitions, especially since it's a formal notice required by the AMF.
2024-03-07 French
LUMIBIRD : COMMANDES DE TÉLÉMÈTRES LASER POUR LE CV90
Regulatory Filings Classification · 98% confidence The document is a press release dated February 29, 2024, announcing that LUMIBIRD's subsidiary received two significant orders from Saab AB for laser rangefinders (OdiPro) for the CV90 combat vehicle. This announcement details a specific business contract, its value (€11.5 million), and the expected duration (2024 to 2029). It is not a formal regulatory filing like a 10-K, an earnings release (ER), or a dividend notice (DIV). It is a specific corporate event announcement related to defense contracts. Since there is no specific category for 'Contract Award Announcement' or 'Defense Contract News', and it is a general corporate update that is not related to management changes (MANG), director dealings (DIRS), or capital structure (CAP), the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered by more specific codes. However, given the content is a major business development announcement, it often falls under general news releases. Since RNS is the designated fallback for miscellaneous filings, I will use that.
2024-02-29 French
LUMIBIRD RECEIVES LASER RANGEFINDER ORDERS FOR CV90
Regulatory Filings Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and announces a specific business event: receiving major orders for laser rangefinders from Saab AB. It provides key financial details (order value SEK 130 million) and contract duration (2024-2029). It is not a comprehensive annual report (10-K), an interim report (IR), or a transcript (CT). Crucially, it ends by announcing the 'Next meeting: Annual results 2023, Tuesday 12 March 2024, after close of trading'. This structure—a news announcement about operational/contract wins, followed by a notice about an upcoming financial results release—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing significant operational news rather than just the financial highlights themselves, and it doesn't fit other specific categories like M&A (TAR) or Capital Change (CAP), it most closely aligns with the function of an Earnings Release (ER) which often includes operational highlights alongside the announcement of the upcoming full results, or it could be classified as a general Regulatory Filing (RNS). Given the context of financial reporting, an ER is often used for major operational updates preceding the formal results announcement, but since this is primarily a contract win announcement, and not the actual financial results themselves, the most appropriate general category for a non-standard, timely announcement is RNS, as it is a regulatory filing that doesn't fit the specific financial report types. However, if we interpret 'Earnings Release' broadly as a press release related to the reporting cycle, ER might apply. Given the strong focus on a contract win and the explicit mention of the *upcoming* annual results date, this functions as a general corporate update/news release. I will classify it as RNS (Regulatory Filings) as the best fallback for a press release detailing operational news that isn't a formal financial statement or a specific corporate action announcement.
2024-02-29 English
LUMIBIRD : nombre d'actions au 31 janvier 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (860 characters) and presents a table detailing the 'Nombre total de droits de vote et d'actions' (Total number of voting rights and shares) as of a specific date (January 31, 2024). This structure, referencing French regulatory articles (Code de commerce and AMF General Regulation), strongly suggests a mandatory disclosure regarding the company's capital structure and voting power. This type of mandatory disclosure, which is not a full report (like 10-K or IR) but a specific regulatory update on share capital/voting rights, fits best under 'Share Issue/Capital Change' (SHA) or potentially 'Regulatory Filings' (RNS) if SHA is too specific. Given the explicit focus on the total number of shares and voting rights, SHA is the most precise fit, as it relates directly to the capital structure.
2024-02-16 French
LUMIBIRD : CHIFFRE D’AFFAIRES 2023 À 203,6 M€
Earnings Release Classification · 100% confidence The document is a press release dated January 29, 2024, announcing the 'CHIFFRE D'AFFAIRES 2023' (2023 Revenue) for LUMIBIRD. It provides key financial highlights for the full year 2023, including revenue figures, EBITDA margin expectations, and segment breakdowns. This content—a preliminary announcement of periodic financial results (annual in this case, but presented as a release before the full audited report)—aligns perfectly with the definition of an Earnings Release (ER). Although it covers the full year, the format is a concise press release summarizing results, not the comprehensive 10-K filing itself. The document explicitly states that the 'Résultats annuels 2023' (Annual Results 2023) will follow on March 12, 2024, confirming this document is the preliminary release. FY 2023
2024-01-29 French
LUMIBIRD: 2023 REVENUES AT €203.6M
Earnings Release Classification · 100% confidence The document is explicitly titled "PRESS RELEASE" and announces the company's 2023 revenues (€203.6M) and expected EBITDA margin, providing detailed financial breakdowns by quarter, division, and geography for the full year 2023 compared to 2022. This format, focusing on preliminary or key financial highlights immediately following the period close, strongly indicates an Earnings Release (ER). It is not a comprehensive Annual Report (10-K) as it mentions the full results meeting is scheduled for March 12, 2024, suggesting this is the preliminary announcement. It is too detailed for just a Report Publication Announcement (RPA) and contains core financial results, ruling out ER as a fallback. FY 2023
2024-01-29 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.